Ontogenetic Market, By Light Equipment (Laser and Light-emitting Diode (LED)), By Actuator (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), By Sensor (Calcium (Aequorin, Cameleon, and Other Calcium Sensors), Chloride (Clomeleon), Membrane-gated (Mermaid), and Other Sensors), By Application (Neuroscience, Behavioral, Tracking, Retinal Disease Treatment, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Ontogenetic is the developmental history of an organism within its lifetime, as distinct from phylogeny, which refers to the evolutionary history of species. Ontogenetic development can be conceptualized as the portion of physical, cognitive, emotional, and social development. It is a vast subject and continuous research in the field is expanding its applications.
Market Dynamics:
Increasing burden of neurological disorders, rising geriatric population, increase in research and development and government initiatives to encourage research, technological advancements in the field of ontogenesis, and increase in adoption of ontogenetic technology are major factors expected to drive growth of the global ontogenetic market.
For instance, according to the Centers for Disease Control and Prevention (CDC), more than 5.8 million people in the United States have Alzheimer’s disease and related dementias, including 5.6 million people aged 65 and older and about 200,000 under age 65 with younger-onset Alzheimer’s.
Moreover, according to the Alzheimer’s Disease International (Alzint.org), someone in the world develops dementia every 3 seconds. There are over 55 million people around the world living with dementia in 2020. This number will almost double every 20 years, reaching around 78 million in 2030 and 139 million in 2050.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook